top of page
Scientist

ABOUT APRICELL

OUR STORY

Apricell Biotechnology Inc. is dedicated to reducing the attrition rate of new cancer drugs in clinical trials.  In collaboration with the University, Apricell has developed a novel Organoid-on-a-Plate technology that opens up multiple opportunities for researchers and oncologists all the way from basic research and drug testing to advanced patient management

MEET THE TEAM

Picture1 (2)_edited.png

Dr. Amir Seyfoori, PhD Founder and CEO

PHOTO-2025-04-30-07-52-32_edited.jpg

Amir Reza Aref, PhD
Chief  Technology Officer

PHOTO-2025-03-10-17-43-29_edited.jpg

Elham Zabihi, PhD
Marketing Strategy Lead

Picture1_edited.jpg

Gurneil Brar
Desig and Model Development 

2Mh5oJIg_400x400_edited.jpg

Dr. Mohsen Akbari, PhD
Scientific Advisor, Engineering

Picture1.jpg

Samuel Mercer, PhD
Business Advisor

OUR SUPPORTERS

1622240095537-removebg-preview.png
images-removebg-preview.png
NRC-IRAP-removebg-preview.png
UVic-mark-removebg-preview.png
unnamed.jpg
Screen-Shot-2016-08-09-at-4.08.32-PM-removebg-preview.png
logo-lime_2-removebg-preview.png
MitacsLogoSm_1.jpg
bottom of page